BJC recorded revenues of $4.22 billion in the first nine months of 2019, up from $3.97 billion in the same period of the year prior, according to unaudited financial documents. The increase was largely attributable to higher net patient service revenue, which climbed 7 percent year over year.
After factoring in expenses, which grew 4 percent year over year, BJC ended the first three quarters of 2019 with operating income of $170.6 million. That’s up 123 percent from operating income of $76.6 million in the same period a year earlier.
More articles on healthcare finance:
CMS’ final outpatient, physician payment rules for 2020: 9 things to know
Chicago hospital halts some services, cuts more than half its beds
CMS penalizes 2,583 hospitals for high readmissions: 5 things to know
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
